Concepedia

M Beresford

MB

2

Publications

136

Citations

2

H-Index

1992

Active since

Affiliations

Roche (Switzerland)(Current)

M Beresford is an author at Roche (Switzerland) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

MedicinePharmacologyPharmacotherapyOncologyImmunologyPhysiologyHypertensionBreast CancerImmunotherapyCancer Therapy

Publications per year

1992–2019

2

Publications

2

Intracerebroventricular angiotensin II‐induced thirst and sodium appetite in rat are blocked by the AT1 receptor antagonist, Losartan (DuP 753), but not by the AT2 antagonist, CGP 42112B

M Beresford, JT Fitzsimons · Experimental Physiology · 1992 · 89 citations · Full text

Hypertension, Subtype 2, Cardiovascular Pharmacology +17

Abstract PD3-01: Results from KATE2, a randomized phase 2 study of atezolizumab (atezo)+trastuzumab emtansine (T-DM1) vs placebo (pbo)+T-DM1 in previously treated HER2+ advanced breast cancer (BC)

LA Emens, Francisco J. Esteva, M Beresford et al. · Cancer Research · 2019 · 47 citations

Breast Oncology, Immunology, Immunoediting +20

Rows per page

1–2 of 2